San Mateo, CA-based health research and data company Evidation has raised $45 million in Series D funding.

B Capital Group led the round, which includes new investors McKesson Ventures and Section 32 as well as existing investors Revelation Partners, Rethink Impact, and SV Health Investors.

B Capital’s Adam Seabrook has joined Evidation’s board.

In another development, Sam Marwaha, senior partner at Boston Consulting Group and long-time advisor to Evidation, joins the company as chief Commercial Officer.

[Image courtesy: Evidation]